Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
12,788,628
-
Share change
-
-1,049,714
-
Total reported value
-
$38,879,024
-
Price per share
-
$3.04
-
Number of holders
-
38
-
Value change
-
-$2,507,850
-
Number of buys
-
19
-
Number of sells
-
14
Institutional Holders of CYTEIR THERAPEUTICS INC - COM (CYTT) as of Q4 2023
As of 31 Dec 2023 CYTEIR THERAPEUTICS INC - COM (CYTT) had 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 12,788,628 shares of stock of the company.
Largest 10 holders included BML Capital Management, LLC, Newtyn Management, LLC, GABELLI FUNDS LLC, Anson Funds Management LP, GABELLI & Co INVESTMENT ADVISERS, INC., VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, Walleye Capital LLC, Laurion Capital Management LP, and Bulldog Investors, LLP.
This table shows 38 institutional shareholders of the security as of 31 Dec 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.